ChronoScale Holdings Corp

CHRN
Country: United StatesPrice: $9.95Market Cap: $1.4B

Investment snapshot

0%positive consensus
Scored 1d ago

Positive

0

BUY / PASS

Neutral / negative

1 / 15

NEUTRAL / FAIL

Median fair value

—

No comparable estimates

Models with upside

0 / 17

Positive margin of safety

Strongest signal

7 of 12 pass — Graham, Buffett, Lynch +2 more object

Key risk

No clean pass — all 16 investors flag at least one profitability criterion

Framework analysis

VerdictMeaning
BUYPositive purchase signal: the framework's buy requirements are met.
PASSThe company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRALNeither a positive nor negative conclusion. It does not mean to hold an existing position.
FAILThe company does not clear the framework's requirements.
RankedRanked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

MetricGraham

Defensive Value

Buffett

Quality Compounder

Lynch

GARP

Greenblatt

Magic Formula

Piotroski

F-Score

Dreman

Contrarian Value

Munger

Quality Focus

Pabrai

Dhandho Framework

Akre

Three-Legged Stool

Marks

Risk-Aware Value

Ackman

Activist Value

Templeton

Global Bargain Hunter

Sleep

Scale Economies Shared

Asness

Systematic Factors

Neff

Low-P/E Total Return

Schloss

Asset-Value Discipline

O'Shaughnessy

Systematic Factor Composite

VerdictFAILFAILFAILFAIL · Rank #2356 (Top 76.1%)FAILFAILFAILFAILFAILFAILFAILFAILFAILFAILFAILFAILNEUTRAL
Score
AnalysisChecking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…
Intrinsic Value (annual)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Margin of SafetyN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Financial Basis

Annual history · FY 2025

Latest source filing: 2026-02-23

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-02-23

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-02-23

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-02-23

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-02-23

Score computed: 2026-11-14

Annual history · FY 2025 · Market data at 2026-11-01

Latest source filing: 2026-02-23

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025

Latest source filing: 2026-02-23

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025

Latest source filing: 2026-02-23

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-02-23

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-02-23

Score computed: 2026-11-14

Annual history · FY 2025 · Market data at 2026-11-01

Latest source filing: 2026-02-23

Score computed: 2026-11-14

Annual history · FY 2025 · Price history 2025-01-01–2026-11-01

Latest source filing: 2026-02-23

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-02-23

Score computed: 2026-11-14

Annual history · FY 2025 · Price history 2025-01-01–2026-11-01

Latest source filing: 2026-02-23

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-02-23

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-02-23

Score computed: 2026-11-14

Annual history · FY 2025 · Price history 2025-01-01–2026-11-01

Latest source filing: 2026-02-23

Score computed: 2026-11-14

Where It Passes

  • Debt & Leverage58% pass✓ 10✗ 5▾

    7 of 12 pass — Graham, Buffett, Lynch +2 more object

    LT Debt vs Net Current Assets
    ✗GrahamLT Debt <= Net Current Assets
    Debt/Equity & Interest CoverageD/E: 0.23, IC: -112.9x
    ✗BuffettD/E < 0.5 AND Interest Coverage > 5x
    Total Debt / Equity0.23
    ✓Lynch< 0.33
    Cash - Long-term Debt
    ✗LynchPositive preferred
    LT Debt / Total Assets Change0.00% -> 0.00%
    ✓PiotroskiDecreased YoY
    Current Assets / Current Liabilities1.63
    ✓Dreman> 1.5✓SchlossCurrent ratio >= 1.50x (app cutoff)
    Total Debt / Shareholders' Equity0.23
    ✓Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00x
    Debt Levels0.23
    ✓MungerDebt/Equity < 0.5✓AkreDebt/Equity < 0.3
    Interest Coverage & Debt/EBITDAIC=-112.9x, D/EBITDA=N/A
    ✗MarksInterest Coverage > 3x; Debt/EBITDA < 4x
    Total Debt / Shareholders Equity0.23
    ✓Ackman<= 1.0
    Negative debt-to-equity (higher means less debt)-0.2269; #1779/4210 (top 42.3%)
    ✗AsnessTop 30% of eligible cross-section

Where It Falls Short

  • Profitability0% pass✓ 2✗ 33▾

    No clean pass — all 16 investors flag at least one profitability criterion

    Positive EPS (10 years)0/15 years positive
    ✗GrahamPositive EPS every year for 10 years
    EPS Growth (3-yr avg, 10-yr window)N/A (negative base EPS)
    ✗Graham>= 33% growth
    Net Income Positive (10+ years)0/15 years positive
    ✗BuffettPositive every year for 10+ years
    ROE (up to 5-year arithmetic mean)-85.0%
    ✗Buffett> 15% arithmetic mean (app rule)
    Operating Margin (10-yr trend)-104.1% (latest)
    ✓BuffettStable or rising over 10 years
    Free Cash Flow Proxy$-10.3M
    ✗BuffettPositive and growing
    Earnings Variance (10-yr CoV)N/A (negative mean EPS)
    ✗BuffettCoV < 0.3
    Retained Earnings Effectiveness
    ✗Buffett$1 retained -> > $1 market value created
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    ROE-129.6%
    ✗Lynch> 15%
    EBIT / Enterprise Value-0.9%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=-0.9%, ROC=-240.9%
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Net Income / Total Assets-58.15%
    ✗PiotroskiROA > 0
    ROA Change YoY-42.51% -> -58.15% (delta: -15.64%)
    ✗PiotroskiCurrent ROA > Prior ROA
    (CFO / Total Assets) vs ROACFO/Assets=-58.68%, ROA=-58.15%
    ✗PiotroskiCFO/Assets > ROA
    Gross Margin Change YoY53.1% -> 53.5%
    ✓PiotroskiImproved YoY
    Pre-Tax Income / Revenue-91.4%
    ✗Dreman>= 8%
    Net Income / Shareholders' Equity-129.6%
    ✗Dreman> 12%
    Margin of SafetyP/B=3.9x
    ✗PabraiP/B < 1.5 or P/E < 15
    Return on Equity-113.1% (3-yr avg)
    ✗AkreROE > 20% (3-year avg)
    Discount to Intrinsic ValueN/A (negative normalized EPS)
    ✗Marks>= 20% below intrinsic value
    Positive Net Income Frequency0/14 years positive
    ✗MarksPositive net income in >= 7 of last 10 years
    Operating Income / Revenue-104.1%
    ✗Ackman>= 15%
    Net Income / Shareholders Equity-129.6%
    ✗Ackman>= 15%
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Operating Margin Trend-82.7% (2023) -> -104.1% (2025)
    ✗TempletonNon-negative operating-margin trend over 3 years
    Revenue growth vs. gross and operating margin trendgross margin 49.7% -> 53.5%, operating margin -82.7% -> -104.1%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    Net income / market capitalization-0.81%; #3375/6340 (top 53.2%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Gross profit / total assets+34.04%; #1211/3702 (top 32.7%)
    ✗AsnessTop 30% of eligible cross-section
    Net income / positive book equity-129.56%; #4712/5226 (top 90.2%)
    ✗AsnessTop 30% of eligible cross-section
    Negative 5-year standard deviation of ROA-0.1334; #3826/5884 (top 65.0%)
    ✗AsnessTop 30% of eligible cross-section
    3-5 Year Diluted EPS CAGR
    ✗Neff7%-20% annualized
    Positive Diluted-EPS Years0/10 years positive
    ✗Schloss>= 70% positive over 5-10 observed years (app rule)
  • Valuation0% pass✓ 1✗ 27▾

    No clean pass — all 13 investors flag at least one valuation criterion

    Price / 3-yr avg EPS
    ✗Graham<= 15x
    Price-to-Book Ratio3.9x
    ✗Graham<= 1.5x
    P/E x P/B
    ✗Graham<= 22.5
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    EBIT / Enterprise Value-0.9%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=-0.9%, ROC=-240.9%
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Price / EPS
    ✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
    Price / (CFO / Shares)N/A (negative CFPS)
    ✗Dreman< 8x
    Price / Book Value per Share3.9x
    ✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)
    Valuation ReasonablenessOE Yield=-29.1%
    ✗MungerP/E < 25 or Owner Earnings Yield > 5%
    P/E or FCF YieldFCF Yield=-0.8%
    ✗PabraiP/E < 15 or FCF Yield > 10%
    P/B or P/E vs. Historical AverageP/B=3.9x
    ✗MarksP/E < 15 or P/B < 2.0
    Discount to Intrinsic ValueN/A (negative normalized EPS)
    ✗Marks>= 20% below intrinsic value
    Price / FCF per ShareN/A (negative FCF)
    ✗Ackman<= 25
    Price vs. Trailing Low302% of trailing low ($3.29)
    ✗Templeton<= 120% of trailing low (certified split-adjusted live window)
    Net income / market capitalization-0.81%; #3375/6340 (top 53.2%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Positive book equity / market capitalization+0.0062; #5201/6449 (top 80.6%)
    ✗AsnessTop 30% of eligible cross-section
    Price / Diluted EPS
    ✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
    (EPS CAGR % + Dividend Yield %) / P/E
    ✗Neff> 0.7 (Neff's published traditional edge)
    Price / Tangible Book Value per Share6.96x
    ✗SchlossP/TBV <= 1.00x (app cutoff)
    Book Value per Share Change+377.0%
    ✓SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
    Revenue / market capitalization+0.0089; #4872/5247 (top 92.9%)
    ✗OshaughnessyTop 10% of eligible cross-section
    (Operating cash flow - capex) / market capitalization-0.83%; #2647/4519 (top 58.6%)
    ✗OshaughnessyTop 10% of eligible cross-section
    Trailing six-month price return through the evaluation date-45.81%; #5011/6202 (top 80.8%)
    ✗OshaughnessyTop 10% of eligible cross-section
  • Cash Flow0% pass✗ 12▾

    All 10 investors flag CHRN's cash flow

    Free Cash Flow Proxy$-10.3M
    ✗BuffettPositive and growing
    FCF Positive and Growing$-12.0M
    ✗LynchPositive and growing
    Operating Cash Flow$-11.8M
    ✗PiotroskiCFO > 0
    (CFO / Total Assets) vs ROACFO/Assets=-58.68%, ROA=-58.15%
    ✗PiotroskiCFO/Assets > ROA
    Price / (CFO / Shares)N/A (negative CFPS)
    ✗Dreman< 8x
    P/E or FCF YieldFCF Yield=-0.8%
    ✗PabraiP/E < 15 or FCF Yield > 10%
    FCF Positive0/14 years FCF positive
    ✗MarksPositive FCF in majority of recent years
    (OCF - CapEx) / Market Cap-33.8%
    ✗Ackman>= 4%
    Price / FCF per ShareN/A (negative FCF)
    ✗Ackman<= 25
    Positive Operating Cash Flow frequency0/14 years positive
    ✗SleepPositive OCF in >= 70% of available years
    Operating Cash Flow - Capital Expenditures$-12.0M
    ✗Neff> $0 (app proxy for a strong fundamental case)
    (Operating cash flow - capex) / market capitalization-0.83%; #2647/4519 (top 58.6%)
    ✗OshaughnessyTop 10% of eligible cross-section
  • Growth0% pass✓ 2✗ 11▾

    No clean pass — all 8 investors flag at least one growth criterion

    EPS Growth (3-yr avg, 10-yr window)N/A (negative base EPS)
    ✗Graham>= 33% growth
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    Inventory Growth vs Revenue GrowthInv: 5.5% vs Rev: -28.6%
    ✗LynchInventory growth < Revenue growth
    EPS Growth Direction$0.00 (2012) -> $-4.91 (2025)
    ✗DremanPositive over recent years
    EPS CAGR
    ✗Dreman> 5% annualized
    Positive Net Income Frequency0/14 years positive
    ✗MarksPositive net income in >= 7 of last 10 years
    3yr Median Revenue Growth-1.9%
    ✗Ackman>= 5%
    Positive EPS Growth Frequency3/5 years with positive EPS growth
    ✓AckmanPositive EPS growth in >= 3 of last 5 years
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Revenue growth vs. gross and operating margin trendgross margin 49.7% -> 53.5%, operating margin -82.7% -> -104.1%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    5-year Revenue CAGR7.6%
    ✓SleepCAGR > 7%
    3-5 Year Diluted EPS CAGR
    ✗Neff7%-20% annualized
  • Verdicts0% pass✗ 16▾

    Split decision: 15 FAIL · 1 NEUTRAL

    Overall verdict
    ✗GrahamFAIL (0/9)✗BuffettFAIL (1/9)✗LynchFAIL (1/7)✗GreenblattRank #2356✗PiotroskiFAIL (F-Score 2)✗DremanFAIL (3/11)✗MungerFAIL (1/4)✗PabraiFAIL (0/3)✗AkreFAIL (2/6)✗MarksFAIL (0/5)✗AckmanFAIL (3/9)✗TempletonFAIL (2/8)✗SleepFAIL (2/6)✗AsnessFAIL (Rank #1516/2370 (Top 64.0%))✗NeffFAIL (1/6)✗SchlossFAIL (3/7)•OshaughnessyNEUTRAL (Not ranked)
  • Efficiency13% pass✓ 1✗ 10▾

    7 of 8 flag CHRN's efficiency — Graham, Buffett, Greenblatt +4 more

    Current Ratio1.63
    ✗Graham>= 2.0
    ROIC (3-5 yr avg)-7988.6%
    ✗Buffett> 10%
    ROIC - WACC-7998.6%
    ✗BuffettPositive (WACC = 10%)
    EBIT / (NWC + Net Fixed Assets)-240.9%
    ✗Greenblatt> 25%
    Current Ratio Change YoY2.50 -> 1.63
    ✗PiotroskiIncreased YoY
    Revenue / Total Assets Change YoY0.67x -> 0.64x
    ✗PiotroskiImproved YoY
    Current Assets / Current Liabilities1.63
    ✓Dreman> 1.5
    Return on Invested Capital-95.1%
    ✗Munger> 15%
    ROIC (high and growing)FY2023: ROIC=-63.9%; FY2024: ROIC=-46.4%; FY2025: ROIC=-95.1%
    ✗AkreLatest 3 consecutive FYs: ROIC > 15% in each
    Reinvestment Rate x ROICN/A (non-positive net income)
    ✗AkreReinvestment Rate * ROIC > 10%
    ROIC (5-year)0/5 years above 12% (latest -95.1%)
    ✗SleepROIC > 12% in a majority of years

Business & financials

Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.

Company Profile

Industry: Machinery
SIC Sector: Industrial Machinery & Computing
Size: Small Cap($1.4B)
Revenue: $12.8M-28.6% YoY
Net Income: $11.7M-3.2% YoY

Financial Snapshot

Operating Margin-104.1%
Return on Equity-129.6%
Debt / Equity0.23
Current Ratio1.63
EPS (Diluted)$-4.91
Shares Retired−140.8%

Similar Companies

LRCXLAM RESEARCH CORP
$282.2B
CATCATERPILLAR INC
$274.6B
DEDEERE & CO
$181.6B
JCIJohnson Controls International plc
$84.4B

Shareholder Return

Fiscal 2025

Issued 140.8% of shares last year.

Buybacks
—
Dividends
—

Company Financials

Latest TTM and quarters alongside annual years

TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.

MetricTTM · 2025-12-31

2025-01-01 – 2025-12-31

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, depreciation amortization, capex, revenue, net income, operating income, gross profit, ebit, interest expense.

Q4 FY 2025

2025-10-01 – 2025-12-31

Sources · derived quarter values

Derived from cumulative filings: revenue, net income, operating income, gross profit, ebit, interest expense, operating cash flow, depreciation amortization, capex.

Q3 FY 2025

2025-07-01 – 2025-09-30

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, depreciation amortization, capex.

Q2 FY 2025

2025-04-01 – 2025-06-30

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, depreciation amortization, capex.

Q1 FY 2025

2025-01-01 – 2025-03-31

Sources
FY 2025
Sources
  • 10-K · 2026-02-23
FY 2024
Sources
  • 10-K · 2025-03-03
FY 2023
Sources
  • 10-K · 2024-03-04
FY 2022
Sources
  • 10-K · 2023-03-28
FY 2021
Sources
  • 10-K · 2022-02-24
Market Cap$1.4Bcurrent--------$31.0Mest.$796.2Kest.$510.0Mest.$338.2Mest.$460.8Mest.
Revenue$12.8M↓29%$3.1M↓38%$4.2M↑2%$2.1M↓58%$3.4M↓10%$12.8M↓29%$17.9M↓2%$18.3M↑42%$12.9M↑15%$11.2M
Operating Income-$13.3M↓27%-$4.5M↓102%-$1.4M↑47%-$4.0M↓70%-$3.4M↓6%-$13.3M↓27%-$10.5M↑31%-$15.1M↑3%-$15.6M↓12%-$13.8M
Net Income-$11.7M↓3%-$4.7M↓37%-$1.4M↑31%-$2.7M↓12%-$2.9M↑16%-$11.7M↓3%-$11.3M↑25%-$15.2M↓1%-$15.1M↓54%-$9.8M
EPS (Diluted)----$-0.54↓440%$-1.24↓854%$-0.12↑40%$-4.91↑42%$-8.43↓666%$-1.10↑5%$-1.16↓32%$-0.88
Gross Margin53.5%↑1%53.2%60.3%↑13%39.8%↓25%53.5%↑3%53.5%↑1%53.1%↑7%49.7%↑3%48.1%↓20%60.0%
Operating Margin-104.1%↓78%-143.6%↓228%-33.2%↑48%-193.2%↓310%-101.9%↓18%-104.1%↓78%-58.4%↑29%-82.7%↑31%-120.5%↑2%-123.0%
ROE-129.6%↓45%————-129.6%↓45%-89.2%↑26%-120.6%↓103%-59.3%↓126%-26.2%
Total Debt$2.0M↓60%$2.0M↓60%$2.3M↓57%$4.6M↓18%$4.8M↓17%$2.0M↓60%$5.1M↓16%$6.1M$6.1M↑205%$2.0M
Shareholders' Equity$9.0M↓29%$9.0M↓29%$9.7M↓35%$10.9M↓9%$12.7M↓10%$9.0M↓29%$12.7M↑1%$12.6M↓50%$25.4M↓32%$37.2M
Current Ratio1.63↓35%1.63↓35%1.66↓41%2.38↓2%2.35↓16%1.63↓35%2.502.49↓26%3.37↓52%6.97
Debt / Equity0.23↓44%0.23↓44%0.24↓33%0.42↓10%0.38↓8%0.23↓44%0.40↓17%0.48↑102%0.24↑346%0.05
Operating Cash Flow-$11.8M↓20%-$4.3M↓202%-$2.1M↑9%-$3.4M↓29%-$2.0M↑43%-$11.8M↓20%-$9.8M↑18%-$12.1M↑18%-$14.7M↓32%-$11.2M
Free Cash Flow-$12.0M↓21%-$4.5M↓207%-$2.1M↑9%-$3.5M↓30%-$2.0M↑43%-$12.0M↓21%-$9.9M↑19%-$12.2M↑18%-$14.9M↓33%-$11.2M

Score history

Historical Score Timeline

Industry peers

Industry Peers

Similar companies in Machinery

CHRN vs Peers — Financial Grading

Revenue$12.8MBottom 25%
Net Income$11.7MBottom 25%
ROE-129.6%Bottom 25%
D/E0.23Top 25%
Op. Margin-104.1%Bottom 25%
Curr. Ratio1.63Median
CompanyMarket CapPriceRevenueNet IncomeROED/EOp. MarginCurr. RatioGrahamBuffettLynchGreenblattPiotroskiDreman
LAM RESEARCH CORPLRCX$282.2B$225.92$23.2B$7.3B58.3%0.3035.3%2.633/95/95/71/3F-Score 85/11
CATERPILLAR INCCAT$274.6B$600.20$67.6B$8.9B41.7%1.7016.5%1.442/95/94/71/3F-Score 65/11
DEERE & CODE$181.6B$673.54$45.7B$5.0B19.4%0.5313.7%—2/96/94/70/3F-Score 54/11
Johnson Controls International plcJCI$84.4B$139.33$23.6B$3.3B25.5%0.71—0.932/91/94/71/3F-Score 64/11
CUMMINS INCCMI$61.9B$452.18$33.7B$3.0B23.9%0.5612.0%1.762/94/93/71/3F-Score 67/11
ITT INC.ITT$18.8B$211.18$3.9B$488.0M11.9%0.1917.4%2.582/94/93/71/3F-Score 53/11
REGAL REXNORD CORPRRX$11.7B$176.41$5.9B$279.5M4.1%0.7011.5%2.153/91/91/71/3F-Score 63/11
GRACO INCGGG$11.6B$72.42$2.2B$521.8M19.7%0.0027.9%3.154/97/94/71/3F-Score 75/11